Immunocore Holdings Stock Performance
IMCR Stock | USD 58.47 1.16 2.02% |
The company retains a Market Volatility (i.e., Beta) of 0.96, which attests to possible diversification benefits within a given portfolio. Immunocore Holdings returns are very sensitive to returns on the market. As the market goes up or down, Immunocore Holdings is expected to follow. Immunocore Holdings has an expected return of -0.26%. Please make sure to check out Immunocore Holdings potential upside, as well as the relationship between the rate of daily change and relative strength index , to decide if Immunocore Holdings performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Immunocore Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's fundamental indicators remain relatively invariable which may send shares a bit higher in May 2024. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors. ...more
Actual Historical Performance (%)
One Day Return 0.63 | Five Day Return 5.78 | Year To Date Return (19.50) | Ten Year Return 33.5 | All Time Return 33.5 |
1 | Is Immunocore Holdings PLC - ADR Stock at the Top of the Biotechnology Industry - InvestorsObserver | 01/30/2024 |
2 | Acquisition by Bahija Jallal of 281819 shares of Immunocore Holdings at 70.5 subject to Rule 16b-3 | 02/16/2024 |
3 | Disposition of 3394 shares by Berman David M of Immunocore Holdings at 71.97 subject to Rule 16b-3 | 02/27/2024 |
4 | RTW Investments LP Grows Stock Position in Immunocore Holdings plc | 03/06/2024 |
5 | Immunocore Trading 3 percent Higher - MarketBeat | 03/22/2024 |
6 | Disposition of 4375 shares by St Leger Tina Amber of Immunocore Holdings at 64.06 subject to Rule 16b-3 | 04/01/2024 |
7 | Immunocore executive sells shares worth over 280,000 | 04/03/2024 |
8 | Immunocore Shares Down 4.2 percent - MarketBeat | 04/09/2024 |
9 | Immunocore Holdings plc Stock Holdings Lessened by Allspring Global Investments Holdings LLC - MarketBeat | 04/19/2024 |
Begin Period Cash Flow | 402.5 M |
Immunocore |
Immunocore Holdings Relative Risk vs. Return Landscape
If you would invest 6,998 in Immunocore Holdings on January 26, 2024 and sell it today you would lose (1,151) from holding Immunocore Holdings or give up 16.45% of portfolio value over 90 days. Immunocore Holdings is currently does not generate positive expected returns and assumes 2.3422% risk (volatility on return distribution) over the 90 days horizon. In different words, 20% of stocks are less volatile than Immunocore, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
Risk |
Immunocore Holdings Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Immunocore Holdings' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Immunocore Holdings, and traders can use it to determine the average amount a Immunocore Holdings' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.112
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | IMCR |
Estimated Market Risk
2.34 actual daily | 20 80% of assets are more volatile |
Expected Return
-0.26 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.11 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Immunocore Holdings is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Immunocore Holdings by adding Immunocore Holdings to a well-diversified portfolio.
Immunocore Holdings Fundamentals Growth
Immunocore Stock prices reflect investors' perceptions of the future prospects and financial health of Immunocore Holdings, and Immunocore Holdings fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Immunocore Stock performance.
Return On Equity | -0.16 | ||||
Return On Asset | -0.0674 | ||||
Profit Margin | (0.22) % | ||||
Operating Margin | (0.26) % | ||||
Current Valuation | 2.5 B | ||||
Shares Outstanding | 48.76 M | ||||
Price To Book | 6.09 X | ||||
Price To Sales | 11.29 X | ||||
Revenue | 249.43 M | ||||
Gross Profit | 54.11 M | ||||
EBITDA | (38.47 M) | ||||
Net Income | (55.29 M) | ||||
Cash And Equivalents | 208.06 M | ||||
Cash Per Share | 4.74 X | ||||
Total Debt | 84.03 M | ||||
Debt To Equity | 0.41 % | ||||
Current Ratio | 3.98 X | ||||
Book Value Per Share | 7.42 X | ||||
Cash Flow From Operations | 2.94 M | ||||
Earnings Per Share | (1.40) X | ||||
Market Capitalization | 2.79 B | ||||
Total Asset | 597 M | ||||
Retained Earnings | (744.67 M) | ||||
Working Capital | 389.8 M | ||||
About Immunocore Holdings Performance
To evaluate Immunocore Holdings Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Immunocore Holdings generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Immunocore Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Immunocore Holdings market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Immunocore's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.Last Reported | Projected for Next Year | ||
Days Of Inventory On Hand | 1.6 K | 1.7 K | |
Return On Tangible Assets | (0.09) | (0.1) | |
Return On Capital Employed | (0.13) | (0.14) | |
Return On Assets | (0.09) | (0.1) | |
Return On Equity | (0.15) | (0.16) |
Things to note about Immunocore Holdings performance evaluation
Checking the ongoing alerts about Immunocore Holdings for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Immunocore Holdings help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.Immunocore Holdings generated a negative expected return over the last 90 days | |
The company reported the previous year's revenue of 249.43 M. Net Loss for the year was (55.29 M) with profit before overhead, payroll, taxes, and interest of 54.11 M. | |
Over 84.0% of the company shares are owned by institutional investors | |
Latest headline from news.google.com: Immunocore Holdings plc Stock Holdings Lessened by Allspring Global Investments Holdings LLC - MarketBeat |
- Analyzing Immunocore Holdings' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Immunocore Holdings' stock is overvalued or undervalued compared to its peers.
- Examining Immunocore Holdings' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Immunocore Holdings' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Immunocore Holdings' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Immunocore Holdings' stock. These opinions can provide insight into Immunocore Holdings' potential for growth and whether the stock is currently undervalued or overvalued.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Immunocore Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. To learn how to invest in Immunocore Stock, please use our How to Invest in Immunocore Holdings guide.Note that the Immunocore Holdings information on this page should be used as a complementary analysis to other Immunocore Holdings' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Complementary Tools for Immunocore Stock analysis
When running Immunocore Holdings' price analysis, check to measure Immunocore Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunocore Holdings is operating at the current time. Most of Immunocore Holdings' value examination focuses on studying past and present price action to predict the probability of Immunocore Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immunocore Holdings' price. Additionally, you may evaluate how the addition of Immunocore Holdings to your portfolios can decrease your overall portfolio volatility.
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
CEOs Directory Screen CEOs from public companies around the world | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |
Is Immunocore Holdings' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Immunocore Holdings. If investors know Immunocore will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Immunocore Holdings listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.68) | Earnings Share (1.40) | Revenue Per Share 5.102 | Quarterly Revenue Growth 0.122 | Return On Assets (0.07) |
The market value of Immunocore Holdings is measured differently than its book value, which is the value of Immunocore that is recorded on the company's balance sheet. Investors also form their own opinion of Immunocore Holdings' value that differs from its market value or its book value, called intrinsic value, which is Immunocore Holdings' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Immunocore Holdings' market value can be influenced by many factors that don't directly affect Immunocore Holdings' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Immunocore Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine if Immunocore Holdings is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Immunocore Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.